Published in Am J Hypertens on December 01, 1992
Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients? Br J Gen Pract (2000) 1.01
Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model. PLoS One (2013) 0.87
Is there a link between the circulating renin-angiotensin system and coronary disease? A buoyant view. Heart (1996) 0.79
Individualised selection of antihypertensive therapy. Drugs (1993) 0.77
Angiotensin converting enzyme inhibition of renin system activity induces reversal of hypertensive target organ changes. Do these effects predict a reduction in long-term morbidity? Am J Hypertens (1992) 0.75
Molecular analysis of commensal host-microbial relationships in the intestine. Science (2001) 12.04
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet (1991) 9.57
Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). Leukemia (2007) 3.33
Effects of clonidine withdrawal: possible mechanisms and suggestions for management. Br Med J (1973) 2.87
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer (2007) 2.36
Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension (1998) 2.31
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17
Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16
Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension. Acta Med Scand (1973) 2.10
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med (1996) 1.98
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol (2001) 1.94
Renal protective effect of enalapril in diabetic nephropathy. BMJ (1992) 1.88
Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography. J Nucl Med (1996) 1.87
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer (2003) 1.86
Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens (1992) 1.73
The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Press (1994) 1.70
Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J (Clin Res Ed) (1986) 1.65
[There is no reason to avoid calcium antagonists in hypertension]. Lakartidningen (1996) 1.62
Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. BMJ (1990) 1.62
Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest (1981) 1.60
Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions. Ann Intern Med (1989) 1.53
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients. Br J Clin Pharmacol (1984) 1.53
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet (2001) 1.52
Capsaicin-induced cough in humans. Am Rev Respir Dis (1992) 1.49
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment. J Hypertens (2000) 1.48
A 5-year prospective, observational study of the withdrawal of antihypertensive treatment in elderly people. J Intern Med (1994) 1.46
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens (1998) 1.46
Organization and efficacy of an out-patient hypertension clinic. Acta Med Scand (1978) 1.45
Captopril effect on hypertension in patient with renin-producing tumour. Lancet (1979) 1.42
Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron (1993) 1.42
Noise as a contributory factor in the development of elevated arterial pressure. A study of the mechanisms by which noise may raise blood pressure in man. Acta Med Scand (1980) 1.42
Controlled study of atenolol in treatment of hypertension. Br Med J (1975) 1.41
Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension. Am J Hypertens (1992) 1.39
Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension. Am J Hypertens (1991) 1.39
Consensus on diuresis renography for investigating the dilated upper urinary tract. Radionuclides in Nephrourology Group. Consensus Committee on Diuresis Renography. J Nucl Med (1996) 1.37
Test characteristics of the Hopkins Symptom Check List-25 (HSCL-25) in Sweden, using the Present State Examination (PSE-9) as a caseness criterion. Soc Psychiatry Psychiatr Epidemiol (1993) 1.36
Urinary concentration test with desmopressin. Br Med J (1978) 1.34
Twice-daily propranolol treatment for hypertension. Lancet (1971) 1.31
Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand (1974) 1.28
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens (2000) 1.26
Renal function and biopsy findings in patients on long-term lithium treatment. Kidney Int (1981) 1.24
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21
A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol. Eur J Clin Pharmacol (1976) 1.21
Malignant hypertension--improving prognosis in a rare disease. Acta Med Scand (1979) 1.21
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens (2001) 1.19
Propranolol given twice daily in hypertension. Acta Med Scand (1973) 1.19
GFR measurement with iohexol and 51Cr-EDTA. A comparison of the two favoured GFR markers in Europe. Nephrol Dial Transplant (1998) 1.19
Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin. Hypertension (1988) 1.17
Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension. J Hypertens (1984) 1.16
STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension. Blood Press (1993) 1.15
STOP-Hypertension--preliminary communication from the pilot study of the Swedish Trial in Old Patients with Hypertension. J Hypertens Suppl (1987) 1.14
Effects of captopril in Bartter's syndrome. N Engl J Med (1981) 1.14
Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J Hypertens (1990) 1.13
Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function. Clin Pharmacokinet (1980) 1.13
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol (2001) 1.12
Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity. Acta Med Scand Suppl (1973) 1.10
Objective social outcomes index (SIX): a method to summarise objective indicators of social outcomes in mental health care. Acta Psychiatr Scand (2008) 1.10
Hypertension in the elderly. Hypertension seminars at Ostra Hospital, Göteborg, Sweden. Acta Med Scand (1981) 1.09
Prolonged exposure to a stressful stimulus (noise) as a cause of raised blood-pressure in man. Lancet (1977) 1.09
Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade. J Hypertens Suppl (1983) 1.08
Does drug treatment improve survival in mild-to-moderate hypertension? J Hypertens (1995) 1.07
Relation of maternal blood pressure during pregnancy to birth weight and blood pressure in children. The Hypertension in Pregnancy Offspring Study. J Intern Med (1994) 1.07
Felodipine, an arteriolar dilator with pronounced antihypertensive effect. Lancet (1983) 1.07
Changes in glycosylation of human bile-salt-stimulated lipase during lactation. Arch Biochem Biophys (2000) 1.07
Increased sympathetic nerve activity in renovascular hypertension. Circulation (1999) 1.06
Diet and the risk of papillary and follicular thyroid carcinoma: a population-based case-control study in Sweden and Norway. Cancer Causes Control (1997) 1.06
Effective dose range of enalapril in mild to moderate essential hypertension. Br J Clin Pharmacol (1985) 1.05
Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist. Acta Med Scand (1983) 1.05
Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood pressure. Hum Mol Genet (2007) 1.04
Long-term effects of losartan on blood pressure and left ventricular structure in essential hypertension. J Hum Hypertens (1996) 1.04
Lithium-induced uraemia. Lancet (1979) 1.03
The Nordic Study on schizophrenic patients living in the community. Subjective needs and perceived help. Eur Psychiatry (2001) 1.02
The validity of Antonovsky's Sense of Coherence measure in a sample of schizophrenic patients living in the community. J Adv Nurs (2001) 1.02
Prediction of later hypertension following a hypertensive pregnancy. J Hypertens Suppl (1983) 1.02
The role of beta-1-adrenoceptors in the renin release response to graded renal sympathetic nerve stimulation. Pflugers Arch (1980) 1.01
Primary hypertension refractory to triple drug treatment: a study on central and peripheral hemodynamics. Circulation (1978) 1.01
Psychiatric morbidity in primary public health care: a multicentre investigation. Part II. Hidden morbidity and choice of treatment. Acta Psychiatr Scand (1997) 1.01
Captopril and atenolol combined with hydrochlorothiazide in essential hypertension. Br J Clin Pharmacol (1982) 1.00
Psychiatric morbidity in primary public health care: a Nordic multicentre investigation. Part I: method and prevalence of psychiatric morbidity. Acta Psychiatr Scand (1995) 1.00
Renal function in normo- and hypertensive 50-year-old males. Acta Med Scand (1976) 1.00
Quantitative and qualitative aspects of the social network in schizophrenic patients living in the community. Relationship to sociodemographic characteristics and clinical factors and subjective quality of life. Int J Soc Psychiatry (2001) 0.98
Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study. Cancer Epidemiol Biomarkers Prev (1996) 0.98
Propranolol in hypertension. Report on 158 patients treated up to one year. Klin Wochenschr (1972) 0.97
Controlled trial of nifedipine and bendroflumethiazide in hypertension. J Cardiovasc Pharmacol (1984) 0.96
Patient satisfaction with inpatient psychiatric care. The influence of personality traits, diagnosis and perceived coercion. Acta Psychiatr Scand (1994) 0.96
Clinical and social needs of schizophrenic outpatients living in the community: the relationship between needs and subjective quality of life. Soc Psychiatry Psychiatr Epidemiol (1999) 0.96
Captopril treatment of hypertension and renal failure in systemic lupus erythematosus. Nephron (1984) 0.95
Blood pressure reduction and vascular adaptation. A study on long-term effects of treatment with mefruside or atenolol. Acta Med Scand (1979) 0.95
Accuracy of a first diagnosis of asthma in primary health care. Fam Pract (2002) 0.95
A distal enhancer region in the human beta-casein gene mediates the response to prolactin and glucocorticoid hormones. Gene (1998) 0.95